articleTop 10% cited
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
Journal of Neurology · 1997 · Vol. 244(3) · pp. 153–159
Enrico Millefiorini✉Claudio Gasperini(Sapienza University of Rome)Carlo Pozzilli(Sapienza University of Rome)Francesco D’Andrea(University of L'Aquila)Alessandro Bozzao(University of L'Aquila)A Calò(University of Bari Aldo Moro)M. Bernini(Federico II University Hospital)D. Gambi(University of Chieti-Pescara)Massimiliano Prencipe(University of L'Aquila)Stefano Bastianello(Sapienza University of Rome)María Trojano(University of Bari Aldo Moro)Vincenzo Brescia Morra(Federico II University Hospital)Stefania Morino(Sapienza University of Rome)
Multiple Sclerosis Research StudiesPolyomavirus and related diseasesFungal Plant Pathogen ControlMitoxantroneMedicineMultiple sclerosisExpanded Disability Status ScalePlaceboNeurologyRandomizationClinical trialRandomized controlled trialInternal medicine
MeSH terms
Adjuvants, ImmunologicAdolescentAdultFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMitoxantroneMultiple SclerosisPlacebosRecurrenceRemission InductionTreatment Outcome
Citations
271
FWCI
2.98
field-weighted impact
References
23
Percentile
91%
vs. same field & year
Citations per year
References
Rating neurologic impairment in multiple sclerosis
Neurology · 1983 · 14,811 citations
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Annals of Neurology · 1983 · 7,391 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
